SOURCE: EastBridge Investment Group

August 12, 2008 08:00 ET

EastBridge Investment Group's Client HuanWai Pharmaceutical Expands to Urumqi

PHOENIX, AZ--(Marketwire - August 12, 2008) - EastBridge Investment Group (EBIG) (OTCBB: EBIG) today announced its client HuanWai Pharmaceutical (HWP) has opened a distribution center in Urumqi, capital of Xinjiang province of China. This will facilitate HuanWai in distributing its pharmaceutical products in this fast growing city of western China. EBIG expects that HuanWai will become an OTCBB listed company six months after the audit's completion. EastBridge's audit team will be doing a site visit in early September.

HWP started in 1999 and has spent its formative years doing R&D, clinical testing and in applying for the licenses for its medicines and setting up its production facility. Today, HWP has obtained over 50 approvals to sell over the counter drugs to control, alleviate or cure high blood pressure, arthritis, intestinal ailments and skin irritations.

EastBridge divides its clients into three annual revenue sizes: Growth: one-ten million dollars; Market-Niche: ten-twenty million dollars; Market-Leader: above twenty million dollars. HWP is in the Growth category with the potential to grow significantly larger after it goes public in the United States.

Depending on the complexity and size of each project, EastBridge normally is compensated with anywhere from 10-25% stock ownership in the client company, plus some cash fees for the listing services provided.

To view an analyst's report by Chris Gupta, CFA, senior equity stock analyst:

EastBridge Investment Group focuses on high-growth companies in Asia, offering IPOs, Joint Ventures and Merchant Banking services. The Company targets industries in electronics, real estate, auto, metal, energy, environmental, bioscience and food retail distribution. To learn more about EastBridge Investment Group go to our web site: To receive EBIG's email alert, send a blank email to

Forward-Looking Statements

Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The Company has no obligation to update these forward-looking statements.

Contact Information

  • Contact:
    Norm Klein
    EastBridge Investment Group Corp.
    480-966-0808 (fax)
    Email Contact

    Investor Relations:
    Jack Eversull
    The Eversull Group, Inc.
    972-378-7981 (fax)
    Email Contact